首页>
外国专利>
HERSTATIN OR INTRON 8-ENCODED DOMAIN THEREOF FOR MODULATING SIGNALING MEDIATED BY IGF-1 RECEPTOR AND ERBB RECEPTORS
HERSTATIN OR INTRON 8-ENCODED DOMAIN THEREOF FOR MODULATING SIGNALING MEDIATED BY IGF-1 RECEPTOR AND ERBB RECEPTORS
展开▼
机译:用于调节IGF-1受体和ERBB受体介导信号的HERSTATIN或INTRON 8编码域
展开▼
页面导航
摘要
著录项
相似文献
摘要
The binding interactions between herstatin, or the intron 8-encoded receptor binding domain (RBD Int8) thereof, and several receptors were analyzed. According to aspects of the present invention, herstatin and the intron 8-encoded domain bind with high affinity (e.g., nM concentrations) to all four of the ErbB receptors: EGFR (HER-1, erbB-1); HER-2 (erbB-2); HER-3 (erbB-3); and HER-4 (erbB-4), as well as to DeltaEGFR and the IGF-1 receptor, and such binding has utility to modulate signaling mediated by these receptors. Herstatin inhibited target receptor-mediated activation of intracellular signaling pathways ((e.g., PI3/Akt, IRS-2, etc., pathways) that are important in cell survival, and further inhibited target receptor-mediated (e.g., IGF-1/IGF-1R-mediated) survival of cancer cells. Aspects of the present invention thus provide methods and compositions for the treatment of cancer, including cancer refractory to other erbB-based agents, and of other conditions and disorders characterized by target receptor expression, over-expression, signaling, and/or aberrant signaling. Additional aspects provide methods of targeted drug delivery.
展开▼